Study of BPN14770 in Participants With Severe Renal Impairment and Healthy Controls
NCT07012005
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Impairment
Interventions
DRUG:
BPN14770
Sponsor
Shionogi